标题
An oral SARS-CoV-2 M
pro
inhibitor clinical candidate for the treatment of COVID-19
作者
关键词
-
出版物
SCIENCE
Volume 374, Issue 6575, Pages 1586-1593
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2021-11-03
DOI
10.1126/science.abl4784
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- AT-527, a double prodrug of a guanosine nucleotide analog, is a potent inhibitor of SARS-CoV-2 in vitro and a promising oral antiviral for treatment of COVID-19
- (2021) Steven S. Good et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A comparative analysis of SARS-CoV-2 antivirals characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19
- (2021) Maren de Vries et al. JOURNAL OF VIROLOGY
- SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
- (2021) Angela Wahl et al. NATURE
- SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model
- (2021) Jingxin Qiao et al. SCIENCE
- A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2021) Shin-ichiro Hattori et al. Nature Communications
- α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
- (2020) Linlin Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- Organic Cation Transporters (OCTs) in EpiAirway™, a Cellular Model of Normal Human Bronchial Epithelium
- (2020) Amelia Barilli et al. Biomedicines
- A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice
- (2020) Sarah R. Leist et al. CELL
- Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
- (2020) Robert L. Hoffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging
- (2020) Wioletta Rut et al. Nature Chemical Biology
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
- (2016) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates
- (2015) Rolando Cannalire et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors
- (2013) Allan M. Prior et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
- (2013) Pillaiyar Thanigaimalai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacokinetic/Pharmacodynamic Predictors of Clinical Potency for Hepatitis C Virus Nonnucleoside Polymerase and Protease Inhibitors
- (2012) Micaela B. Reddy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
- (2012) Sho Konno et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases
- (2012) Chi-Pang Chuck et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses
- (2012) Y. Kim et al. JOURNAL OF VIROLOGY
- Linking Crystallographic Model and Data Quality
- (2012) P. A. Karplus et al. SCIENCE
- Data processing and analysis with theautoPROCtoolbox
- (2011) Clemens Vonrhein et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Development of a new permeability assay using low‐efflux MDCKII cells
- (2011) Li Di et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Molecular replacement withMOLREP
- (2009) Alexei Vagin et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Darunavir
- (2009) Kate McKeage et al. DRUGS
- Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery
- (2007) Valerie Grum-Tokars et al. VIRUS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now